WO2022088724A1 - Green tea active substance mouthwash composition and preparation method therefor - Google Patents
Green tea active substance mouthwash composition and preparation method therefor Download PDFInfo
- Publication number
- WO2022088724A1 WO2022088724A1 PCT/CN2021/102917 CN2021102917W WO2022088724A1 WO 2022088724 A1 WO2022088724 A1 WO 2022088724A1 CN 2021102917 W CN2021102917 W CN 2021102917W WO 2022088724 A1 WO2022088724 A1 WO 2022088724A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- green tea
- active substance
- mouthwash composition
- cyclodextrin
- tea
- Prior art date
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 168
- 239000002324 mouth wash Substances 0.000 title claims abstract description 109
- 229940051866 mouthwash Drugs 0.000 title claims abstract description 104
- 235000009569 green tea Nutrition 0.000 title claims abstract description 84
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 239000013543 active substance Substances 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims description 26
- 235000013616 tea Nutrition 0.000 claims abstract description 107
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 72
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 62
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 39
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229940041616 menthol Drugs 0.000 claims abstract description 39
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 37
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 37
- 229960004853 betadex Drugs 0.000 claims abstract description 37
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 36
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 36
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 35
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 35
- 239000000600 sorbitol Substances 0.000 claims abstract description 35
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 35
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 34
- 150000004676 glycans Chemical class 0.000 claims abstract description 34
- 235000011187 glycerol Nutrition 0.000 claims abstract description 34
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 34
- 239000005017 polysaccharide Substances 0.000 claims abstract description 34
- 239000000811 xylitol Substances 0.000 claims abstract description 34
- 235000010447 xylitol Nutrition 0.000 claims abstract description 34
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 34
- 229960002675 xylitol Drugs 0.000 claims abstract description 34
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims abstract description 33
- 239000003755 preservative agent Substances 0.000 claims abstract description 20
- 230000002335 preservative effect Effects 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 10
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 62
- 239000000243 solution Substances 0.000 claims description 47
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 45
- 239000011734 sodium Substances 0.000 claims description 45
- 229910052708 sodium Inorganic materials 0.000 claims description 45
- 229940026510 theanine Drugs 0.000 claims description 31
- 239000000796 flavoring agent Substances 0.000 claims description 30
- 235000019634 flavors Nutrition 0.000 claims description 30
- 239000000049 pigment Substances 0.000 claims description 27
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 25
- UYTOHYBIBPDOKX-ZDUSSCGKSA-N (2s)-2-(dodecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@@H](C)C(O)=O UYTOHYBIBPDOKX-ZDUSSCGKSA-N 0.000 claims description 23
- 239000000022 bacteriostatic agent Substances 0.000 claims description 21
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims description 21
- 229940093265 berberine Drugs 0.000 claims description 21
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 claims description 21
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 20
- 229960003767 alanine Drugs 0.000 claims description 20
- 235000004279 alanine Nutrition 0.000 claims description 20
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 20
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 20
- 229960005055 sodium ascorbate Drugs 0.000 claims description 20
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 20
- 229940094952 green tea extract Drugs 0.000 claims description 12
- 235000020688 green tea extract Nutrition 0.000 claims description 12
- 235000005979 Citrus limon Nutrition 0.000 claims description 11
- 244000131522 Citrus pyriformis Species 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 11
- 229910021641 deionized water Inorganic materials 0.000 claims description 11
- 239000002671 adjuvant Substances 0.000 claims description 9
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 5
- 235000010234 sodium benzoate Nutrition 0.000 claims description 5
- 239000004299 sodium benzoate Substances 0.000 claims description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 229960003191 potassium methylparaben Drugs 0.000 claims description 2
- 235000019640 taste Nutrition 0.000 abstract description 20
- 239000000463 material Substances 0.000 abstract description 12
- 230000003385 bacteriostatic effect Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 13
- 241000191967 Staphylococcus aureus Species 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000009385 viral infection Effects 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 241000712461 unidentified influenza virus Species 0.000 description 5
- 208000036142 Viral infection Diseases 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 241000700584 Simplexvirus Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- -1 etc. Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 229940095518 mouthwash product Drugs 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- XXBNLUKLCXTTPH-MGCNEYSASA-N (2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoyl chloride Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(Cl)=O XXBNLUKLCXTTPH-MGCNEYSASA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 206010061298 Mucosal haemorrhage Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940041678 oral spray Drugs 0.000 description 1
- 239000000668 oral spray Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
Definitions
- the present application relates to the field of personal care, in particular to a green tea active substance mouthwash composition and a preparation method thereof.
- the mouth is the first gateway for food to enter the human body, and it is also the window between the human ecosystem and the outside world. If food residues in the mouth are not cleaned up in time, they will undergo chemical changes under the action of enzymes in saliva, creating a breeding ground for pathogenic bacteria. These pathogenic bacteria will destroy the body's own ecosystem, causing various discomforts and symptoms. Although brushing your teeth can solve some of the problems, gargling with a mouthwash is still the most efficient way to clean your mouth.
- Cipheral Patent No. CN200910088890.5 discloses a kind of multifunctional pure natural mouthwash and its preparation method, its alcohol content is too high, it is well known that alcohol can cause dry mouth, destroy the mucus protective layer that keeps the mouth moist, and cause a tingling sensation , not suitable for daily long-term use.
- the content of tea polyphenols in the active substance is insufficient and cannot play a bacteriostatic effect.
- Patent No. CN201611192684.5 discloses a green tea active substance mouthwash for oral care and a preparation method thereof, and the chemical additive sodium monofluorophosphate contained in the formula.
- Patent No. CN2015103329316 discloses a natural mouthwash based on tea extract and its preparation method.
- the content of natural active substances such as tea polyphenols, chlorogenic acid is low, and the antibacterial effect is limited, and the antibacterial depends on other antibacterial components , such as alcohol, methylparaben, etc.
- the present application provides a green tea active substance mouthwash composition, which solves the problems of the antibacterial safety of the existing mouthwash and the irritation in the mouthfeel.
- the green tea active substance mouthwash composition includes: bacteriostatic substances, which are 0.5-2wt% of tea polyphenols; auxiliary materials, including:
- the preservatives include:
- the tea polyphenols account for 0.5-1.7 wt % of the green tea active substance mouthwash composition.
- the auxiliary materials include:
- the auxiliary materials include:
- the auxiliary materials include:
- the auxiliary materials include:
- the adjuvant further includes: essence ⁇ 3wt%; and/or pigment ⁇ 5wt%.
- the composition includes:
- the antibacterial substance is 0.5-0.7wt% of tea polyphenols
- Excipients including:
- the composition includes:
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- a method for preparing a green tea active substance mouthwash composition comprising the following steps: taking predetermined weight parts of tea polyphenols and hydroxypropyl- ⁇ -cyclodextrin, dissolving them in deionized water , form solution 1; take predetermined weight portions of glycerin, sorbitol, beta cyclodextrin menthol, tea polysaccharide, preservative, xylitol, theanine, dissolve in deionized water, form solution 2; evenly mix the described The solution 1 and the solution 2 are supplemented with water, and filtered and sterilized to obtain a green tea active substance mouthwash composition.
- predetermined weight portions of glycerol, sorbitol, beta-cyclodextrin menthol, tea polysaccharide, preservatives, xylitol and theanine are dissolved in deionized water to form solution 2.
- the uniformly mixing the solution 1 and the solution 2 further includes: adding a predetermined weight portion of sodium N-lauroyl-L-alanine and/or sodium cocoyl alanine and/or adding a predetermined weight portion of berberine; and/or adding a predetermined weight portion of green tea extract; and/or adding a predetermined weight portion of lemon extract; and adding a predetermined weight portion of flavor and/or pigment.
- the tea polyphenols in the green tea active substance mouthwash composition provided by the present application has a broad-spectrum antibacterial effect, no need to add other antibacterial agents, and the ingredients are safe.
- the effect of essence relieves the irritation on the taste, and the addition of preservatives solves the problem of the effect of oxidation of similar tea-flavored mouthwashes on the antibacterial effect.
- berberine in the present application it and tea polyphenols also have a certain effect in preventing various viral infections.
- Example 1 is a schematic diagram of the bacteriostatic effect of Example 1, Example 2, Example 3 and Example 4 on Staphylococcus aureus;
- Example 5 is a schematic diagram of the bacteriostatic effect of Example 5 of the application on Staphylococcus aureus
- Example 3 is a schematic diagram of the bacteriostatic effect of Example 6, Example 7, Example 8 and Example 9 on Staphylococcus aureus;
- Example 4 is a schematic diagram of the bacteriostatic effect of Example 10, Example 11, Example 12 and Example 13 of the application on Staphylococcus aureus;
- FIG. 5 is a schematic diagram of the bacteriostatic effect of Examples 14 and 15 of the application on Staphylococcus aureus;
- Example 16 is a schematic diagram of the bacteriostatic effect of Example 16 and Example 17 of the application on Staphylococcus aureus;
- Fig. 7 is the antibacterial effect diagram of mouthwash product 1 on the market to Staphylococcus aureus
- Figure 8 is a graph showing the antibacterial effect of mouthwash product 2 on Staphylococcus aureus on the market.
- the application provides a green tea active substance mouthwash composition, which can achieve a high antibacterial effect only by relying on the green tea natural active substance tea polyphenols, and can prevent the occurrence of dental caries and periodontitis by inhibiting the growth of bacteria, which is safe and has no side effects.
- tea polyphenols and berberine While inhibiting bacteria, it will not cause damage to the oral mucosa; tea polyphenols and berberine also have antiviral effects, which can reduce the risk of virus infection from the oral cavity to a certain extent, and realize the effect of mouthwash on influenza virus, hepatitis B virus, Prevention of various viral infections such as herpes simplex virus; adding N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium surfactants can better clean the mouth and freshen breath; additionally use hydroxypropyl Base- ⁇ -cyclodextrin wraps tea polyphenols, and then adds tea polysaccharides, theanine and ⁇ -cyclodextrin menthol to solve the bitterness caused by adding tea polyphenols to mouthwash, and the overall taste is mild and fragrant; by adding preservatives
- the agent solves the problem that tea polyphenols are easily oxidized in mouthwashes and affects the bacteriostatic effect, and truly forms an efficient bac
- tea polyphenols in the composition provided by the present application have broad-spectrum and high-efficiency antibacterial effects both in vitro and in vivo, and research on the antibacterial effects of tea polyphenols shows that tea polyphenols have good bacteriostatic effects on various pathogenic bacteria. Tea polyphenols exert their own antibacterial effects mainly by specifically coagulating bacterial proteins, destroying the cell membrane structure of bacteria, and combining with bacterial DNA, thereby changing the physiological state of bacteria to inhibit their growth. In addition, tea polyphenols can maintain the integrity of oral mucosa while inhibiting bacteria, enhance the toughness and permeability of capillaries, enhance the resistance of blood vessels, quickly heal oral mucosal ulcers, reduce mucosal bleeding, and protect the function of oral mucosa.
- N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium surfactants in this application are new green and environmentally friendly surfactants derived from renewable biomass, compared with other traditional surfactants , N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium have better wettability, foaming, antibacterial, anti-corrosion, antistatic ability and so on.
- N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium surfactants are non-toxic and harmless, mild and non-irritating to the oral cavity, and the degradation products are amino acids and fatty acids, which basically have no impact on the environment, and have Suppresses the action of lactic acid bacteria that convert glucose into lactic acid, and has the effect of cleaning the mouth and refreshing the breath.
- the tea polysaccharide in the adjuvant of the present application is an acidic glycoprotein and is combined with a large amount of mineral elements.
- the protein part is mainly composed of about 20 common amino acids.
- Studies on the active ingredients of tea polysaccharides show that tea polysaccharides have the functions of lowering blood sugar, lowering blood lipids, and preventing and treating diabetes. At the same time, it has obvious effects in anticoagulation, preventing thrombosis, protecting blood phase and enhancing non-specific immunity of human body.
- Theanine in the auxiliary material of the present application is a unique free amino acid in tea, and is the main component of invigorating and moistening sweetness in tea. In addition, it also has the health care effects of relieving fatigue, lowering blood pressure and improving learning and memory ability.
- the hydroxypropyl- ⁇ -cyclodextrin in the adjuvant of the present application can encapsulate the tea polyphenols and reduce the bitterness formed by the combination of phenolic substances and proteins in the oral cavity through sustained release.
- the ⁇ -cyclodextrin menthol in the auxiliary materials of the application can be directly dissolved in the water phase system without ethanol to help dissolve, so the mouthwash of the application is an alcohol-free formula, and the mouthwash has a refreshing taste of mint but no irritation caused by alcohol .
- the preservatives in the auxiliary materials of this application are safe food additives, which can effectively protect the tea polyphenols from being oxidized and maintain the antibacterial effect of the product.
- tea polyphenols and berberine in this application can effectively prevent a variety of viral infections.
- a preparation method of a green tea active substance mouthwash composition comprising the following steps: taking predetermined weight portions of tea polyphenols and hydroxypropyl- ⁇ -cyclodextrin, dissolving them in deionized water, Form solution 1; take predetermined weight portions of glycerin, sorbitol, beta-cyclodextrin menthol, tea polysaccharide, preservatives, xylitol, theanine, dissolve in deionized water to form solution 2; uniformly mix the solution 1 and the solution 2, supplemented with water, filtered and sterilized to obtain a green tea active substance mouthwash composition.
- predetermined weight portions of glycerol, sorbitol, beta-cyclodextrin menthol, tea polysaccharide, preservatives, xylitol and theanine are dissolved in deionized water to form solution 2.
- the uniformly mixing the solution 1 and the solution 2 further includes: adding a predetermined weight portion of sodium N-lauroyl-L-alanine and/or sodium cocoyl alanine and/or adding a predetermined weight portion of berberine; and/or adding a predetermined weight portion of green tea extract; and/or adding a predetermined weight portion of lemon extract; and adding a predetermined weight portion of flavor and/or pigment.
- the tea polyphenols in the present application have broad-spectrum and high-efficiency antibacterial effects in vitro and in vivo, and have obvious inhibitory effects on Gram-positive bacteria.
- the N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium surfactants in the composition of the present application are novel green and environmentally friendly surfactants derived from renewable biomass.
- the tea polysaccharide in the auxiliary material of the present application is an acidic glycoprotein, combined with a large amount of mineral elements, and has obvious effects in protecting the blood phase and enhancing the non-specific immunity of the human body.
- theanine in the adjuvant of the present application is a unique free amino acid in tea leaves, and is the main component of invigorating and moistening sweetness in tea leaves.
- the hydroxypropyl- ⁇ -cyclodextrin in the excipient can encapsulate the tea polyphenols and reduce the bitterness formed by the combination of phenolic substances and proteins in the oral cavity through sustained release.
- the ⁇ -cyclodextrin menthol in the auxiliary material can be directly dissolved in the water phase system without ethanol to help dissolve, so the mouthwash of the present application is an alcohol-free formula, and the mouthwash has a refreshing taste of mint but no irritation caused by alcohol.
- tea polyphenols and berberine in the present application can effectively prevent various viral infections, tea polyphenols can inhibit various stages of the influenza virus growth cycle, and berberine can reduce the infection risk of influenza viruses, such as hepatitis B virus, Herpes simplex virus, HIV, adenovirus, etc.
- influenza viruses such as hepatitis B virus, Herpes simplex virus, HIV, adenovirus, etc.
- the green tea active substance mouthwash composition provided by the present application has safe and natural ingredients, and has a mild and non-irritating taste.
- the invention solves the problems of safety and taste irritation of existing mouthwash books on the market, and also solves the problems of low antibacterial effect of mouthwash with good taste.
- the use of green tea active substances to inhibit bacteria and clean the mouth is more natural, healthier and more in line with the consumption needs of Chinese people.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- a predetermined weight fraction of 1 wt % of tea polyphenols and 2.4 wt % of hydroxypropyl- ⁇ -cyclodextrin were added to the sterilized container, and dissolved with an appropriate amount of deionized water with stirring to form solution 1.
- the solution 1 and the solution 2 obtained in the above steps are mixed evenly, stirred to dissolve, supplemented with deionized water, and filtered and sterilized to obtain a green tea active substance bacteriostatic mouthwash.
- the preparation process is the same as in Example 1.
- the solution 2 when the solution 2 is formed, it also includes adding a predetermined weight portion of essence and pigment.
- Bacteriostatic substance which is 0.8wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the antibacterial substance is 2wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the addition of a predetermined weight portion of sodium N-lauroyl-L-alanine is also included.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the addition of a predetermined weight portion of berberine is also included.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the green tea active substance mouthwash of this embodiment includes the following components:
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- a predetermined weight portion of berberine and sodium N-lauroyl-L-alanine are also added.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- a predetermined weight portion of berberine and sodium N-lauroyl-L-alanine are also added.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- mixing solution 1 and solution 2 it also includes adding a predetermined weight portion of sodium cocoyl alanine.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- mixing solution 1 and solution 2 it also includes adding a predetermined weight portion of sodium cocoyl alanine.
- Bacteriostatic substances which are 1wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the solution 1 and the solution 2 are mixed, it also includes adding a predetermined weight portion of green tea extract.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the solution 1 and the solution 2 are mixed, it also includes adding a predetermined weight portion of green tea extract.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the solution 1 and the solution 2 are mixed, it also includes adding a predetermined weight portion of lemon extract.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- the preparation process is the same as the above-mentioned embodiment.
- the solution 1 and the solution 2 are mixed, it also includes adding a predetermined weight portion of lemon extract.
- Bacteriostatic substance which is 0.5wt% of tea polyphenols
- Excipients including:
- Test samples Examples 1-17, commercially available brands - Mayambine green tea mouthwash (water, sorbitol (sugar) alcohol, propylene glycol, PEG-40 hydrogenated castor oil, tea extract, dipotassium glycyrrhizinate, menthol, three Chlorogalactose, Methylparaben, Sodium Benzoate, Food Flavor, CI 19140, CI 42090), Commercial Brands - Black Green Tea Mouthwash (Water, Glycerin, Propylene Glycol, Sorbitol (Sugar) Alcohol, Poloxamer 407, Flavor (containing tea extract), sodium saccharin, cetylpyridinium chloride (0.075%), sodium fluoride (0.05%), potassium sorbate, menthol, CI19140, CI42051).
- Mayambine green tea mouthwash water, sorbitol (sugar) alcohol, propylene glycol, PEG-40 hydrogenated castor oil, tea extract, dipotassium
- Test strain Staphylococcus aureus ATCC6538
- each contamination plate is pasted with 4 test samples and 1 negative control sample, a total of 5 pieces.
- After the patch is placed gently press the sample with sterile tweezers to make it close to the surface of the plate. Cover the plate well, place in a 37°C incubator, and incubate for 16h to 18h to observe the results.
- the diameter of the bacteriostatic ring (including the patch) was measured with a vernier caliper and recorded. The test was repeated 3 times.
- the bactericidal activity was evaluated by the presence or absence of the inhibition zone and the size of the inhibition zone.
- CK all represent sterile water, and numbers represent examples.
- the diameter of the standard antibacterial ring is greater than 7mm, it is judged to have antibacterial effect; if the diameter of the antibacterial ring is less than or equal to 7mm, it is judged to have no antibacterial effect.
- Test strain Staphylococcus aureus ATCC6538
- Test method According to GB 15979-2002 Hygienic Standard for Disposable Sanitary Products, Test Method for Antibacterial Performance of C4 Dissolution Antibacterial (Inhibitory) Products, each example acts on Staphylococcus aureus for 2min, 5min, 10min, 20min, calculate The bacteriostatic rate is as follows:
- the product According to the standard bacteriostatic rate of 50% to 90%, the product has bacteriostatic effect, and if the bacteriostatic rate is greater than or equal to 90%, the product has a strong bacteriostatic effect.
- a score of 4-5 indicates that the mouthwash has a comfortable taste, the tea flavor is appropriate, mild and not irritating;
- a score of 3-4 indicates that the mouthwash has an average taste, with obvious bitterness of tea, which is an acceptable range;
- a score of 3 or less indicates that the mouthwash is obviously bitter and unacceptable.
- Table 4 The results of the mouthwash taste test score results of the proportion of the number of people in the interval
Abstract
Description
Claims (15)
- 一种绿茶活性物质漱口水组合物,其特征在于,按所述绿茶活性物质漱口水组合物的重量分数,包括:A green tea active substance mouthwash composition, characterized in that, according to the weight fraction of the green tea active substance mouthwash composition, the composition comprises:抑菌物质,为0.5~2wt%的茶多酚;The antibacterial substance is 0.5-2wt% of tea polyphenols;辅料,包括:Excipients, including:甘油 16~24wt%Glycerol 16~24wt%山梨醇 2~8wt%Sorbitol 2~8wt%β环糊精薄荷醇 0.6~1.2wt%β-cyclodextrin menthol 0.6~1.2wt%茶多糖 0.8~1.2wt%Tea polysaccharide 0.8~1.2wt%茶氨酸 0.01~0.05wt%Theanine 0.01~0.05wt%羟丙基-β-环糊精 1.2~4.8wt%Hydroxypropyl-β-cyclodextrin 1.2~4.8wt%防腐剂 0.2~0.4wt%Preservative 0.2~0.4wt%木糖醇 0.8~1.2wt%Xylitol 0.8~1.2wt%水 基于所述绿茶活性物质漱口水组合物的总重量,补足。Water is replenished based on the total weight of the green tea active mouthwash composition.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述茶多酚占所述绿茶活性物质漱口水组合物的重量分数优选为0.5~1.7wt%。The green tea active substance mouthwash composition according to claim 1, wherein the weight fraction of the tea polyphenols in the green tea active substance mouthwash composition is preferably 0.5-1.7 wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述防腐剂包括抗坏血酸钠和/或苯甲酸钠和/或山梨酸钾和/或羟苯甲酯。The green tea active substance mouthwash composition according to claim 1, wherein the preservative comprises sodium ascorbate and/or sodium benzoate and/or potassium sorbate and/or methylparaben.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述辅料包括:The green tea active substance mouthwash composition according to claim 1, wherein the adjuvant comprises:N-月桂酰-L-丙氨酸钠和/或椰油酰丙氨酸钠 0.05~0.15wt%,优选为0.05~0.1wt%。N-lauroyl-L-alanine sodium and/or cocoyl alanine sodium 0.05-0.15wt%, preferably 0.05-0.1wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述辅料还包括:The green tea active substance mouthwash composition according to claim 1, wherein the adjuvant further comprises:黄连素 0.005~0.01wt%,优选为0.005~0.008wt%。Berberine 0.005-0.01wt%, preferably 0.005-0.008wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述辅料还包括:The green tea active substance mouthwash composition according to claim 1, wherein the adjuvant further comprises:绿茶提取物 0.01~0.2wt%,优选为0.05~0.18wt%。Green tea extract 0.01-0.2wt%, preferably 0.05-0.18wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述辅料还包括:The green tea active substance mouthwash composition according to claim 1, wherein the adjuvant further comprises:柠檬提取物 0.01~0.2wt%,优选为0.05~0.18wt%。Lemon extract 0.01-0.2wt%, preferably 0.05-0.18wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,所述辅料还包括:The green tea active substance mouthwash composition according to claim 1, wherein the adjuvant further comprises:香精≤3wt%;和/或Flavor≤3wt%; and/or色素≤5wt%。Pigment≤5wt%.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,按所述绿茶活性物质漱口水组合物的重量分数,包括:The green tea active substance mouthwash composition according to claim 1, wherein, according to the weight fraction of the green tea active substance mouthwash composition, comprising:抑菌物质,为2wt%的茶多酚;The antibacterial substance is 2wt% of tea polyphenols;辅料,包括:Excipients, including:甘油 24wt%Glycerin 24wt%山梨醇 5wt%Sorbitol 5wt%β环糊精薄荷醇 1.2wt%Beta cyclodextrin menthol 1.2wt%茶氨酸 0.01wt%Theanine 0.01wt%茶多糖 1wt%Tea polysaccharide 1wt%羟丙基-β-环糊精 4.8wt%Hydroxypropyl-β-cyclodextrin 4.8wt%防腐剂 0.4wt%Preservative 0.4wt%木糖醇 1wt%Xylitol 1wt%香精 ≤3wt%Flavor ≤3wt%色素 ≤5wt%Pigment ≤5wt%水 基于所述绿茶活性物质漱口水组合物的总重量,补足。Water is replenished based on the total weight of the green tea active mouthwash composition.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,按所述绿茶活性物质漱口水组合物的重量分数,包括:The green tea active substance mouthwash composition according to claim 1, wherein, according to the weight fraction of the green tea active substance mouthwash composition, comprising:抑菌物质,为0.5wt%的茶多酚;Bacteriostatic substance, which is 0.5wt% of tea polyphenols;辅料,包括:Excipients, including:甘油 20wt%Glycerin 20wt%山梨醇 5wt%Sorbitol 5wt%β环糊精薄荷醇 0.8wt%β-cyclodextrin menthol 0.8wt%茶氨酸 0.02wt%Theanine 0.02wt%茶多糖 1wt%Tea polysaccharide 1wt%羟丙基-β-环糊精 1.2wt%Hydroxypropyl-β-cyclodextrin 1.2wt%防腐剂 0.2wt%Preservative 0.2wt%木糖醇 1wt%Xylitol 1wt%黄连素 0.005wt%Berberine 0.005wt%香精 ≤3wt%Flavor ≤3wt%色素 ≤5wt%Pigment ≤5wt%水 基于所述绿茶活性物质漱口水组合物的总重量,补足。Water is replenished based on the total weight of the green tea active mouthwash composition.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,按所述绿茶活性物质漱口水组合物的重量分数,包括:The green tea active substance mouthwash composition according to claim 1, wherein, according to the weight fraction of the green tea active substance mouthwash composition, comprising:抑菌物质,为0.5wt%的茶多酚;Bacteriostatic substance, which is 0.5wt% of tea polyphenols;辅料,包括:Excipients, including:甘油 20wt%Glycerin 20wt%山梨醇 5wt%Sorbitol 5wt%β环糊精薄荷醇 0.8wt%β-cyclodextrin menthol 0.8wt%茶氨酸 0.02wt%Theanine 0.02wt%茶多糖 1wt%Tea polysaccharide 1wt%羟丙基-β-环糊精 1.2wt%Hydroxypropyl-β-cyclodextrin 1.2wt%防腐剂 0.2wt%Preservative 0.2wt%木糖醇 1wt%Xylitol 1wt%N-月桂酰-L-丙氨酸钠和/或椰油酰丙氨酸钠 0.1wt%Sodium N-lauroyl-L-alanine and/or sodium cocoyl alanine 0.1wt%绿茶提取物 0.1%wtGreen Tea Extract 0.1%wt香精 ≤3wt%Flavor ≤3wt%色素 ≤5wt%Pigment ≤5wt%水 基于所述绿茶活性物质漱口水组合物的总重量,补足。Water is replenished based on the total weight of the green tea active mouthwash composition.
- 根据权利要求1所述的绿茶活性物质漱口水组合物,其特征在于,按所述绿茶活性物质漱口水组合物的重量分数,包括:The green tea active substance mouthwash composition according to claim 1, wherein, according to the weight fraction of the green tea active substance mouthwash composition, comprising:抑菌物质,为0.5wt%的茶多酚;Bacteriostatic substance, which is 0.5wt% of tea polyphenols;辅料,包括:Excipients, including:甘油 20wt%Glycerin 20wt%山梨醇 5wt%Sorbitol 5wt%β环糊精薄荷醇 0.8wt%β-cyclodextrin menthol 0.8wt%茶氨酸 0.02wt%Theanine 0.02wt%茶多糖 1wt%Tea polysaccharide 1wt%羟丙基-β-环糊精 1.2wt%Hydroxypropyl-β-cyclodextrin 1.2wt%防腐剂 0.2wt%Preservative 0.2wt%木糖醇 1wt%Xylitol 1wt%N-月桂酰-L-丙氨酸钠和/或椰油酰丙氨酸钠 0.1wt%Sodium N-lauroyl-L-alanine and/or sodium cocoyl alanine 0.1wt%柠檬提取物 0.1%wtLemon Extract 0.1%wt香精 ≤3wt%Flavor ≤3wt%色素 ≤5wt%Pigment ≤5wt%水 基于所述绿茶活性物质漱口水组合物的总重量,补足。Water is replenished based on the total weight of the green tea active mouthwash composition.
- 一种绿茶活性物质漱口水组合物的制备方法,其特征在于,包括以下步骤:A preparation method of a green tea active substance mouthwash composition, characterized in that it comprises the following steps:取预定重量份的茶多酚和羟丙基-β-环糊精,溶解于去离子水中,形成溶液1;Take a predetermined weight portion of tea polyphenols and hydroxypropyl-β-cyclodextrin, dissolve them in deionized water, and form solution 1;取预定重量份的甘油、山梨醇、β环糊精薄荷醇、茶多糖、防腐剂、木糖醇,茶氨酸,溶解于去离子水中,形成溶液2;Get a predetermined weight portion of glycerin, sorbitol, β-cyclodextrin menthol, tea polysaccharide, preservative, xylitol, theanine, dissolve in deionized water, and form solution 2;均匀混合所述溶液1和所述溶液2,补足水,经过滤灭菌处理,获得绿茶活性物质漱口水组合物。The solution 1 and the solution 2 are uniformly mixed, supplemented with water, and filtered and sterilized to obtain a green tea active substance mouthwash composition.
- 根据权利要求9所述的制备方法,其特征在于,所述取预定重量份的甘油、山梨醇、β环糊精薄荷醇、茶多糖、防腐剂、木糖醇和茶氨酸,溶解于去离子水中,形成溶液2。preparation method according to claim 9, is characterized in that, described taking predetermined weight portion of glycerin, sorbitol, beta-cyclodextrin menthol, tea polysaccharide, preservative, xylitol and theanine, dissolved in deionized In water, solution 2 was formed.
- 根据权利要求9所述的制备方法,其特征在于,所述均匀混合所述溶液1和所述溶液2,还包括:The preparation method according to claim 9, wherein the uniformly mixing the solution 1 and the solution 2 further comprises:添加预定重量份的N-月桂酰-L-丙氨酸钠和/或椰油酰丙氨酸钠;和/或Add a predetermined weight portion of sodium N-lauroyl-L-alaninate and/or sodium cocoylalanine; and/or添加预定重量份的黄连素;和/或Add a predetermined weight portion of berberine; and/or添加预定重量份的柠檬提取物;和/或Add a predetermined weight of lemon extract; and/or添加预定重量份的绿茶提取物;和adding a predetermined weight portion of green tea extract; and添加预定重量份的香精和/或色素。Add a predetermined amount by weight of flavor and/or color.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023547730A JP2023546272A (en) | 2020-10-28 | 2021-06-29 | Green tea active substance mouthwash composition and method for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011170295.9A CN114469794A (en) | 2020-10-28 | 2020-10-28 | Green tea active substance mouthwash composition and preparation method thereof |
CN202011170295.9 | 2020-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022088724A1 true WO2022088724A1 (en) | 2022-05-05 |
Family
ID=81383483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/102917 WO2022088724A1 (en) | 2020-10-28 | 2021-06-29 | Green tea active substance mouthwash composition and preparation method therefor |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2023546272A (en) |
CN (1) | CN114469794A (en) |
WO (1) | WO2022088724A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114796260A (en) * | 2022-06-28 | 2022-07-29 | 潍坊护理职业学院 | Oral care composition and preparation method thereof |
CN114983879A (en) * | 2022-07-20 | 2022-09-02 | 成都中医药大学 | Magnolol mouth wash and preparation method thereof |
WO2024016109A1 (en) * | 2022-07-18 | 2024-01-25 | 南京中科游子生物技术研究院有限公司 | Oral care composition of tea active substance and method for preparing same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115068388A (en) * | 2022-07-20 | 2022-09-20 | 广州日行轩营销策划有限公司 | Gargle containing gargle tea polyphenol and preparation method of gargle tea polyphenol |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1377645A (en) * | 2002-04-17 | 2002-11-06 | 于江 | Tea polyphenol buccal tablet for preventing and curing tooth decay and its preparing method |
CN108014070A (en) * | 2018-02-10 | 2018-05-11 | 广州市九科精细化工有限公司 | Visualization propolis acidity mouthwash of hemostasis and anti-inflammation and preparation method thereof |
CN108245684A (en) * | 2018-03-15 | 2018-07-06 | 山东滨州智源生物科技有限公司 | A kind of preparation method of menthol HYDROXYPROPYL BETA-CYCLODEXTRIN inclusion compound |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101627965B (en) * | 2009-07-21 | 2011-03-30 | 清华大学 | Multifunctional pure natural mouthwash and preparation method thereof |
CN104739726B (en) * | 2015-03-30 | 2017-11-21 | 美晨集团股份有限公司 | A kind of Chinese medicine toothpaste and preparation method thereof |
CN106821950A (en) * | 2017-01-23 | 2017-06-13 | 衡阳美娇七商贸有限公司 | The oral care composition and its application of a kind of antibacterial and whitening |
CN108309845A (en) * | 2018-03-07 | 2018-07-24 | 浙江源敏科技有限公司 | A kind of antibacterial mouthwash of pure plant and preparation method thereof |
CN109125176A (en) * | 2018-09-28 | 2019-01-04 | 江苏瑾辉生物科技有限公司 | One kind gargle containing tea polyphenols and preparation method thereof |
CN111228171A (en) * | 2020-01-15 | 2020-06-05 | 拉芳家化股份有限公司 | Preparation method of toothpaste rich in tea amino acid |
CN111346023A (en) * | 2020-04-15 | 2020-06-30 | 广州立白企业集团有限公司 | Plant bacteriostatic composition, mouthwash containing composition and preparation method of mouthwash |
CN111529457B (en) * | 2020-06-19 | 2023-04-28 | 中华全国供销合作总社杭州茶叶研究所 | Tea-containing formula toothpaste capable of regulating flora and preparation method and application thereof |
-
2020
- 2020-10-28 CN CN202011170295.9A patent/CN114469794A/en active Pending
-
2021
- 2021-06-29 JP JP2023547730A patent/JP2023546272A/en active Pending
- 2021-06-29 WO PCT/CN2021/102917 patent/WO2022088724A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1377645A (en) * | 2002-04-17 | 2002-11-06 | 于江 | Tea polyphenol buccal tablet for preventing and curing tooth decay and its preparing method |
CN108014070A (en) * | 2018-02-10 | 2018-05-11 | 广州市九科精细化工有限公司 | Visualization propolis acidity mouthwash of hemostasis and anti-inflammation and preparation method thereof |
CN108245684A (en) * | 2018-03-15 | 2018-07-06 | 山东滨州智源生物科技有限公司 | A kind of preparation method of menthol HYDROXYPROPYL BETA-CYCLODEXTRIN inclusion compound |
Non-Patent Citations (3)
Title |
---|
CUI YUJIA, SUN JIANXUN;ZHOU XUEDONG: "Progress for Understanding the Effect of Berberine in Oral Diseases", INTERNATIONAL JOURNAL OF STOMATOLOGY, vol. 47, no. 1, 31 January 2020 (2020-01-31), pages 115 - 120, XP055926352, ISSN: 1673-5749, DOI: 10.7518/gjkq.2020029 * |
LIU LI: "Discussion on Major Functional Components of Tea and Their Bioactivities", SOUTH CHINA AGRICULTURE, vol. 12, no. 24, 31 August 2018 (2018-08-31), XP055926349, ISSN: 1673-890X, DOI: 10.19415/j.cnki.1673-890x.2018.24.070 * |
WEN ZHAOYU, CHEN MINSHAN, LI YIPING: "Component of Tea and Its Useful Value in Oral Care", TOOTHPASTE INDUSTRY, no. 2, 31 March 2005 (2005-03-31), pages 22 - 23, XP055926346 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114796260A (en) * | 2022-06-28 | 2022-07-29 | 潍坊护理职业学院 | Oral care composition and preparation method thereof |
CN114796260B (en) * | 2022-06-28 | 2022-09-27 | 潍坊护理职业学院 | Oral care composition and preparation method thereof |
WO2024016109A1 (en) * | 2022-07-18 | 2024-01-25 | 南京中科游子生物技术研究院有限公司 | Oral care composition of tea active substance and method for preparing same |
CN114983879A (en) * | 2022-07-20 | 2022-09-02 | 成都中医药大学 | Magnolol mouth wash and preparation method thereof |
CN114983879B (en) * | 2022-07-20 | 2023-12-01 | 成都中医药大学 | Magnolol mouthwash and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2023546272A (en) | 2023-11-01 |
CN114469794A (en) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022088724A1 (en) | Green tea active substance mouthwash composition and preparation method therefor | |
JP4111916B2 (en) | Composition for alleviating xerostomia and treating related diseases | |
KR101763953B1 (en) | Composition for oral cavity | |
CN107184476A (en) | A kind of antibacterial mouthwash and preparation method thereof | |
CZ384898A3 (en) | Antimicrobial preparations for articles intended for oral hygiene | |
JP2010018544A (en) | Antimicrobial agent, composition for oral cavity and denture cleanser | |
CN109646452A (en) | Artificial saliva | |
CA1318599C (en) | Pharmaceutical compositions containing dyclonine hc1 and phenol | |
CN109010098A (en) | Antimicrobial mouthwash and preparation method thereof | |
KR20170103476A (en) | Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract | |
CN111617021B (en) | Toothpaste for resisting oral helicobacter pylori | |
WO2024016109A1 (en) | Oral care composition of tea active substance and method for preparing same | |
JP5386897B2 (en) | Oral composition | |
RU2777153C1 (en) | Composition for oral care for patients with metabolic disorders | |
CN109512683A (en) | A kind of povidone iodine composition and the preparation method and application thereof | |
CN109077946A (en) | The purposes of astaxanthin | |
JP2007091737A (en) | Oral composition | |
KR100665891B1 (en) | Oral hygiene compositions containing hydroxytyrosol | |
KR101818211B1 (en) | Composition for prevention or treatment of oral disease comprising Arctill fructus Extract | |
KR20170103494A (en) | Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract | |
KR20170103482A (en) | Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract | |
KR102548925B1 (en) | Composition for prevention or treatment of oral disease comprising Scopoletin | |
KR102541843B1 (en) | Composition for prevention or treatment of oral disease comprising Arctiin | |
KR20140055885A (en) | The gargle composites for the increment of the oral care | |
WO2022216263A1 (en) | A new toothpaste containing rosa damascena (isparta oil rose) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21884465 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023547730 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21884465 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21884465 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21884465 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 16/11/2023) |